UK Health Agency Reviews Warnings for Dopamine Agonist Medications After Error in Patient Leaflets Identified
** A UK government review is underway after an investigation found widespread errors in patient leaflets for dopamine agonist medications, which are used to treat conditions like Parkinson's disease and restless legs syndrome. The Medicines and Healthcare products Regulatory Agency (MHRA) aims to ensure accurate and up-to-date information is provided to patients.

Iran proposes seven‑day timetable
Tasia Fortune’s hanging was ‘staged’ after her death in a drug dispute, police say
6 People Are Missing After Explosion in Athens Tourist District
Carney Seeks New Trade Partners for Canada, But Knows the Limits
Colombia’s President Wears Gun to Santa Marta, City Shut Down by a Criminal Group